
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇨🇦CA · Medicine#1495K to 30K
- 🇸🇬SG · Medicine#883K to 10K
- 🇵🇹PT · Medicine#128500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.5K to 13K🎙 Daily cadence·1,000 episodes·Last published 2d ago - Monthly Reach
Unique listeners across all episodes (30 days)
8.5K to 43K🇨🇦70%🇸🇬23%🇵🇹7% - Active Followers
Loyal subscribers who consistently listen
3.4K to 17K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 25 epsHost
Recent guests
Recent episodes
Changing the Clinical Value Equation in Orthopedic Care with Nic Aldrich, Vice President of Marketing at OrthAlign
Jun 25, 2026
15m 48s
Using AI to Strengthen Clinical Confidence in Procedures with Will Mauldin, Co-Founder and CEO of Rivanna Medical
Jun 23, 2026
11m 38s
From Blind Biopsies to Precision: Reinventing Medical Imaging with Reza Khorasaninejad, Founder & CEO at LEADOPTIK
Jun 22, 2026
12m 29s
Building Bridges Across the Healthcare Ecosystem with Adam McMullin, CEO of AvaSure
Jun 18, 2026
16m 08s
Creating the Future of MedTech Through Purpose with James Corbett, transformational MedTech CEO and Board Advisor
Jun 17, 2026
32m 17s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/25/26 | ![]() Changing the Clinical Value Equation in Orthopedic Care with Nic Aldrich, Vice President of Marketing at OrthAlign | Orthopedic procedures are increasingly moving to ambulatory surgery centers, but many navigation technologies remain too expensive, complex, or inefficient for that setting. In this episode, Nic Aldrich, Vice President of Marketing at OrthAlign, discusses how handheld navigation technology is making precision orthopedic care more accessible. He explains how OrthAlign helps surgeons reduce variability, execute patient-specific plans, and bring advanced technology into total hip, knee, partial knee, and revision procedures. Nic also shares how the newly cleared Lantern ASC system was designed specifically for surgery centers, balancing accuracy with cost, speed, and ease of use. Tune in to learn how smaller, more efficient technologies are helping expand access to precision orthopedic care. Resources: Connect with and follow Nic Aldrich on LinkedIn. Follow OrthAlign on LinkedIn and explore their website. Learn more about the Lantern ASC system here. | 15m 48s | ||||||
| 6/23/26 | ![]() Using AI to Strengthen Clinical Confidence in Procedures with Will Mauldin, Co-Founder and CEO of Rivanna Medical | AI in medtech is most valuable when it supports better clinical decisions, not when it replaces clinicians. In this episode, Alexis Anderson speaks with Will Mauldin, Co-Founder and CEO of Rivanna Medical, live from DeviceTalks Boston. Will explains how Rivanna is bringing AI-enabled imaging to clinical settings where providers have traditionally relied on blind or manual procedures, beginning with epidural anesthesia guidance and expanding into fracture detection. He shares how the company’s handheld spine guidance technology helps clinicians visualize the epidural space, use AI as a confirmation tool, and build confidence through consistent outcomes. Will also discusses broader medtech trends around AI, automation, connected devices, and robotics, along with funding challenges for mid-stage companies and Rivanna’s upcoming FDA milestones. Tune in and learn how AI-enabled imaging can improve safety, reduce bottlenecks, and support clinicians in high-demand care environments. Resources Connect and follow Will Mauldin on LinkedIn. Follow Rivanna Medical on LinkedIn and explore their website. | 11m 38s | ||||||
| 6/22/26 | ![]() From Blind Biopsies to Precision: Reinventing Medical Imaging with Reza Khorasaninejad, Founder & CEO at LEADOPTIK | Lung cancer biopsies are still being done blind more often than you’d think, leading to costly diagnostic errors. In this episode, Reza Khorasaninejad, Founder & CEO at LEADOPTIK, discusses how advances in photonics and metasurface engineering are enabling highly miniaturized imaging systems for minimally invasive procedures. These innovations aim to address a major challenge in lung cancer biopsies: a lack of imaging guidance that can lead to significant diagnostic errors. Early clinical pilots across multiple sites are demonstrating strong performance, with one hospital already converting into a paying customer. Looking ahead, the company is partnering with Stanford Medicine to develop AI-driven decision support tools to further improve diagnostic accuracy. Tune in to learn how next-generation imaging and AI are changing that reality and helping physicians hit the right target the first time! Resources: Connect with and follow Reza Khorasaninejad on LinkedIn.Follow LEADOPTIK on LinkedIn and explore their website! | 12m 29s | ||||||
| 6/18/26 | ![]() Building Bridges Across the Healthcare Ecosystem with Adam McMullin, CEO of AvaSure | Healthcare technology only matters when it makes care safer, more accessible, and easier to deliver at scale. In this episode, Adam McMullin, CEO of AvaSure, joins Saul to discuss how virtual care, ambient AI, and smart room platforms are transforming inpatient care. He explains how AvaSure creates a “cocoon of safety” around patients and care teams through capabilities such as fall prevention, violence reduction, and expanded access to specialty care. Adam emphasizes that lasting technology adoption depends on thoughtful clinical workflow design, nurse engagement, open architecture, and strong partner ecosystems. He also shares leadership lessons on values alignment and explains why health systems are increasingly scaling smart room technologies to address financial pressures, workforce shortages, and efficiency demands. Tune in and learn how proven technology, trusted partnerships, and aligned leadership can help health systems deliver safer, smarter care. Resources: Connect with and follow Adam McMullin on LinkedIn. Follow AvaSure on LinkedIn and explore their website! | 16m 08s | ||||||
| 6/17/26 | ![]() Creating the Future of MedTech Through Purpose with James Corbett, transformational MedTech CEO and Board Advisor | MedTech innovation succeeds when bold ideas are matched with disciplined execution, strong teams, and a clear purpose. In this episode, James Corbett, transformational MedTech CEO and Board Advisor, joins Saul to share the leadership lessons, operating principles, and industry changes that have shaped his decades-long career. Drawing on experience leading companies including Boston Scientific, ev3, Alphatec Spine, CathWorks, and AVITA Medical, Jim explains why people and purpose are the foundation of lasting success in healthcare. He discusses the future of MedTech, including the creation of new clinical categories, the importance of operational excellence, and the growing role of AI in leadership and business transformation. Jim also shares why many organizations are underutilizing AI, how his AI command center captures decades of operating knowledge, and why great people remain the ultimate competitive advantage. Tune in and learn how purpose-driven leadership, operational discipline, and AI-enabled execution can help shape the next generation of MedTech innovation! Resources: Connect with and follow James Corbett on LinkedIn. Explore Jim Corbett AI! | 32m 17s | ||||||
| 6/16/26 | ![]() Policy Convergence and the Future of Pharma Value Creation with Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity | The future of market access belongs to organizations that plan years in advance. In this episode, Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity, explains why pharmaceutical companies must prepare now for major market access changes coming in Europe and beyond. He highlights that Joint Clinical Assessments for rare disease assets, beginning in 2028, will require earlier planning, stronger governance, and more integrated evidence-generation strategies. Steve also discusses the complexity created by varying country-specific care pathways, limited comparators, and the growing importance of real-world evidence in rare disease development. Across policy shifts like JCA, IRA, MFN, and new European pharmaceutical legislation, the central message is clear: organizations that anticipate earlier will be better positioned to succeed. Tune in to hear how the future of rare disease market access is being reshaped, and why companies that prepare earlier will have a major strategic advantage! Resources: Connect with and follow Steve Mather on LinkedIn. Follow Lumanity on LinkedIn and explore their website! Learn more about this series we're doing with Lumanity here: https://lumanity.com/commercialization-podcasts/ | 25m 01s | ||||||
| 6/15/26 | ![]() The Future of Medical Robotics: AI, Automation, and Global Growth with KUKA Robotics USA’s Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics | AI is transforming medical robotics, but not in the ways many people expect. In this episode, KUKA Robotics USA’s Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics, discuss how labor shortages, increasing quality demands, and growing interest in AI are shaping the future of medical robotics. While AI is becoming more prevalent in areas such as simulation, collision detection, and path planning, they emphasize that regulatory requirements limit its role in autonomous clinical decision-making. They also highlight KUKA's focus on quality, strategic partnerships, global expansion, and the development of new robotic platforms to support a growing range of medical applications. Tune in to hear how KUKA is navigating the opportunities and challenges of AI, automation, and innovation in healthcare robotics! Resources: Connect with and follow Silke Wendt on LinkedIn. Connect with and follow Corey Ryan on LinkedIn. Follow KUKA Robotics USA on LinkedIn and explore their website! | 6m 12s | ||||||
| 6/11/26 | ![]() How Health Economics Drives Medtech Growth with Christian Howell, CEO of Cognito Therapeutics✨ | Alzheimer's therapyhealth economics+4 | Christian Howell | Cognito Therapeutics | Alzheimer’s | Alzheimer'sCognito Therapeutics+5 | — | 15m 39s | |
| 6/9/26 | ![]() How Health Economics Drives Medtech Growth with Betty Tsai, President of Cardiology Services International✨ | health economicsmedtech growth+3 | Betty Tsai | Cardiology Services InternationalCMS | — | health economicsmedtech+3 | — | 11m 37s | |
| 6/4/26 | ![]() From One Event to a Global Platform: The Rise of MedTech World with Dr. Dylan Attard, CEO and Co-founder of MedTech World✨ | medtechentrepreneurship+3 | Dr. Dylan Attard | MedTech World | MaltaFlorida | MedTech WorldDr. Dylan Attard+3 | — | 8m 52s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 6/2/26 | ![]() Building a scalable pharma launch engine that drives competitive advantage with Lumanity’s Business Development Director, Jeff Hart, and Launch Excellence Principal, Kirsty Tait✨ | pharmaceutical launchstrategic thinking+4 | Jeff HartKirsty Tait | Lumanity | — | pharma launchstrategic frameworks+5 | — | 26m 11s | |
| 5/28/26 | ![]() Reinventing Blood Testing for Better Patient Experience with Web Golinkin, President at Babson Diagnostics✨ | blood testingpatient experience+4 | Web Golinkin | Babson Diagnostics | — | blood drawpatient-friendly+7 | — | 21m 41s | |
| 5/28/26 | ![]() From Innovation to Adoption: What It Really Takes to Win in Medtech with Ken Nelson, Partner and Founder at Nelson Jennings Ventures✨ | medtechinnovation+4 | Ken Nelson | Nelson Jennings VenturesBoston Scientific+5 | — | medtechcardiac devices+5 | — | 6m 36s | |
| 5/27/26 | ![]() Shifting from Denial Management to Denial Prevention with Jason Considine, President of Experian Health✨ | healthcare reimbursementdenial management+4 | Jason Considine | Experian HealthExperian | OBBA | healthcarereimbursement+5 | — | 21m 54s | |
| 5/26/26 | ![]() Building Trustworthy AI in Healthcare with Dr. Peter Bonis, Chief Medical Officer at Wolters Kluwer Health✨ | AI in healthcareclinical decision support+3 | Dr. Peter Bonis | Wolters Kluwer Health | — | AI governancehealthcare innovation+3 | — | 16m 40s | |
| 5/26/26 | ![]() Designing for the End: Bridging Medtech Development and Manufacturing with Amanda Helgeson, Business Development Manager at Forj Medical✨ | medtechstartups+4 | Amanda Helgeson | Forj MedicalMedtech Innovator | — | medtech startupsmanufacturing+4 | — | 9m 14s | |
| 5/22/26 | ![]() Bringing Clarity to Healthcare Payments with Ted Ferrin, SVP of Payments Innovation at Zelis✨ | healthcare paymentspayment transparency+4 | Ted Ferrin | ZelisRivet | — | healthcare paymentstransparency+5 | — | 16m 49s | |
| 5/21/26 | ![]() Reducing Clinician Burden with AI-Powered Workflows with Dr. Richa Gupta, Vice President of Care Transformation at Ambience Healthcare | Healthcare is drowning in documentation and fragmented data, but what if the system worked for clinicians rather than against them? In this episode, Dr. Richa Gupta, Vice President of Care Transformation at Ambience Healthcare, explains how Ambience provides a layer of intelligence on top of electronic medical records to optimize clinician workflow and patient interactions. Ambience’s ambient listening system captures physician-patient interactions, supports documentation, and ensures accurate coding and billing, boosting clinician satisfaction and reducing revenue leakage. ROI is driven by high clinician utilization, validated outcomes, and measurable improvements in documentation burden, coding accuracy, and physician retention. In 2026, Ambience is expanding across the full care continuum, including ambulatory, emergency, and inpatient settings, offering a platform that surfaces real-time insights and enhances patient care. Tune in to hear how Ambience is transforming physician workflows and delivering real ROI across the care continuum! Resources: Connect with and follow Dr. Richa Gupta on LinkedIn. Follow Ambience Healthcare on LinkedIn and visit their website! | 14m 33s | ||||||
| 5/21/26 | ![]() Building Medtech That Can Change Care with Peter Lewis, Executive Vice President of Business Development at Hydrix | Transformational medtech innovation needs more than a great idea. It needs the right engineering, clinical evidence, reimbursement strategy, and commercialization support to reach patients. In this episode, Peter Lewis, Executive Vice President of Business Development at Hydrix, joins Saul Marquez at the MedTech Innovator Radar Forum to discuss what it takes to bring complex, safety-critical medical devices to market. Peter shares Hydrix’s evolution from its origins in Australia to becoming a global medical product development company supporting cardiac, surgical robotics, imaging, neurostimulation, and other advanced technologies. He highlights why clinician-led innovation is especially powerful, what distinguishes today’s most promising medtech startups, and why AI, reimbursement, and human clinical evidence are now essential pillars for growth. Tune in to learn what medtech innovators need to consider early if they want to build solutions that truly change care. Resources: Connect with and follow Peter Lewis on LinkedIn or reach out via email. Explore the Hydrix website here! | 6m 13s | ||||||
| 5/20/26 | ![]() Making Healthcare Technology More Human with Lisa Gulker, Chief Nursing Officer at Oracle Health and Life Sciences | Healthcare technology should quietly remove friction and reduce burden so clinicians can focus on what matters most: caring for patients in a more human way. In this episode, Lisa Gulker, Chief Nursing Officer at Oracle Health and Life Sciences, discusses how Oracle is rethinking healthcare technology by building AI directly into the foundation of its systems rather than layering it on as an afterthought. She explains how this approach can help clinicians spend less time in the chart, reduce workflow fragmentation, and make technology feel more seamless in the care experience. Lisa also shares how Oracle is applying these capabilities across providers, life sciences, and payers, creating opportunities to accelerate research, improve clinical trial matching, streamline prior authorization, and reduce administrative burden across the ecosystem. Throughout the conversation, she brings a nurse leader’s perspective to a central question in healthcare innovation: how do we use technology to make care feel more human, not less? Tune in and learn how embedded AI could reshape the healthcare experience for clinicians, staff, researchers, payers, and patients alike! Resources: Connect with and follow Lisa Gulker on LinkedIn. Follow Oracle Health on LinkedIn and visit their website! | 17m 26s | ||||||
| 5/19/26 | ![]() Empowering Community Health Workers with Technology with Colby Takeda, Co-Founder and CEO of Pear Suite | What happens when some of healthcare’s most trusted workers are still operating outside the systems that document, reimburse, and scale care? In this episode, Colby Takeda, Co-Founder & CEO of Pear Suite, joins Saul Marquez live at ViVE to explore why community health workers are becoming a more essential part of the healthcare ecosystem. Drawing from his background in senior living and public health, Colby explains how Pear Suite helps community-based providers move beyond paper and spreadsheets with tools to document care, navigate credentialing and contracting, submit claims, and get paid for the value they deliver. The conversation also looks at Pear Suite’s broader vision for connecting community-based organizations, health plans, and providers in a more coordinated system of care. Colby shares why AI should reduce administrative burden instead of replacing trusted relationships, how co-design with frontline workers has shaped the platform, and where he sees the biggest opportunity to make community-based care more sustainable and accessible at scale. Tune in to hear how community health workers are becoming more essential to the healthcare ecosystem, and how better infrastructure and smarter technology can make community-based care more sustainable and scalable. Resources: Connect with Colby Takeda on LinkedIn Learn more about Pear Suite Explore Pear Suite for Providers Follow Pear Suite on LinkedIn | 16m 44s | ||||||
| 5/19/26 | ![]() Scaling Complex Medtech With the Right Partners with Dan Purvis, Chairman and Co-Founder of Velentium Medical | Successful medtech commercialization requires founders to know what only they can do best, then bring in the right partners to help scale the rest. In this episode, Dan Purvis, Chairman and Co-Founder of Velentium Medical, joins Saul Marquez at the MedTech Innovator Radar Forum to discuss the evolution of complex medical device development. Dan explains how Velentium was designed to integrate engineering, firmware, mechanical design, cybersecurity, testing, and manufacturing under one roof to better support OEMs from development through production. He also reflects on how medtech innovation has matured, with more companies arriving at events with working technology, animal data, and clearer paths to human use. Finally, Dan emphasizes that successful commercialization requires founders to focus on their strengths, build expert teams, and delegate specialized work. Tune in and learn how medtech companies can move from promising technology to scalable, secure, and patient-impacting solutions. Resources: Follow Velentium Medical on LinkedIn and visit their website here. Connect with Dan Purvis on LinkedIn. | 8m 07s | ||||||
| 5/19/26 | ![]() From Chaos to Confidence: Mastering Pharma Launch as a First-Time Team with Andrew Mooney and Laurence Cooper, Launch Excellence Experts at Lumanity | Launching in pharma, especially for smaller organizations, is a complex, high-pressure marathon, and establishing Launch Excellence fundamentals early is essential for success. In this episode, Andrew Mooney and Laurence Cooper, Launch Excellence Experts at Lumanity, discuss the overwhelming complexity and pressure of pharma launches, especially for smaller or first-time organizations with limited experience, resources, and intense market expectations. They break down five essential fundamentals: insight-driven strategy, strong governance and decision-making, organizational alignment and culture, right-sized team capabilities, and timely resourcing, to help teams build a solid foundation for success. They emphasize the importance of focus and discipline, including defining a clear, winnable segment, building an early, realistic critical path, maintaining an integrated, cross-functional plan, and using honest KPIs and risk planning to avoid costly surprises. They also highlight how smaller organizations can outperform larger competitors by leveraging agility, ruthless prioritization, strong leadership, and early preparation to replace chaos and burnout with clarity, confidence, and control at launch. If you're preparing for a first or early pharma launch and feeling the pressure, this conversation offers a practical blueprint to help you focus, stay ahead of risks, and build the confidence needed to execute successfully! Resources: Connect with and follow Andrew Mooney on LinkedIn. Connect with and follow Laurence Cooper on LinkedIn. Follow Lumanity on LinkedIn and explore their website! Take a look at the 5 Fundamentals here. | 26m 01s | ||||||
| 5/18/26 | ![]() From FDA to Revenue: Where Most Startups Get It Wrong with Ken Nelson, Partner and Founder at Nelson Jennings Ventures, and Omar Khateeb, CEO of MarketCraft | Most medtech startups don’t fail because of bad technology; they fail because no one built the market for it. In this episode, Ken Nelson, Partner and Founder at Nelson Jennings Ventures, and Omar Khateeb, CEO of MarketCraft, share how judging at MedTech Innovator sharpens their perspectives as investors, operators, and mentors by exposing them to diverse expert insights across regulatory, reimbursement, and commercialization. They emphasize that medtech success today requires far more than a great product; founders must actively build market demand and prioritize commercialization early. A major mistake many startups make is assuming acquisition will come easily after FDA approval without demonstrating real market pull and adoption. Ultimately, the best founders balance conviction with coachability while leveraging ecosystems like MedTech Innovator to accelerate growth and de-risk their path. If you’re building, investing in, or advising medtech companies, this conversation will challenge how you think about commercialization, growth, and what actually drives valuation! Resources: Connect with and follow Ken Nelson on LinkedIn. Connect with and follow Omar Khateeb on LinkedIn. Follow MarketCraft on LinkedIn and explore their website! Check out the State of Medtech podcast! | 14m 46s | ||||||
| 5/14/26 | ![]() Using Clinical Analytics to Improve Critical Care with Brian Tufts, President & CEO at Ambient Clinical Analytics | Hospitals already have rich patient data. The next step is turning that data into validated, timely insights that help clinicians respond before patients deteriorate. In this episode, Brian Tufts, President & CEO at Ambient Clinical Analytics, joins Saul Marquez at the MedTech Innovator Radar Forum to explore how software-as-a-medical-device is improving critical care workflows. Brian explains how the company, a Mayo Clinic spinout, built an FDA-cleared platform that combines clinical analytics, decision support, and workflow automation to help hospitals monitor complex patients. He highlights tools like Sepsis DART, which enable earlier detection and response by embedding hospital-specific protocols directly into workflows. Brian also underscores that AI in healthcare must be validated, structured, and carefully implemented, not left to unproven models making clinical decisions. Tune in to learn how hospitals can better leverage data to improve patient care in a thoughtful, reliable way. Resources: Connect with and follow Brian Tufts on LinkedIn. Follow Ambient Clinical Technologies on LinkedIn and explore their website here. | 9m 18s | ||||||
Showing 25 of 1229
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
3 placements across 3 markets.
Chart Positions
3 placements across 3 markets.

























